PANAVIR: EFFICACY IN REGENERATIVE THERAPY FOR DUODENAL ULCERS
The severity and frequency of complications developing in case of hard-to-cicatrize ulcers require that regenerative stimulants should be incorporated into the treatment regimen. The efficacy of Panavir as a regeneration stimulant in the combination therapy of duodenal ulcers was evaluated. Positive changes were noted in 97.5% of cases, including the epithelialization time of torpid duodenal ulcers being reduced by 3 times.